INTRODUCTION
Both long-term synaptic plasticity and behavioral learning require de novo RNA and protein synthesis (Costa-Mattioli et al., 2009) . Several immediate early genes (IEGs) are rapidly induced in response to neuronal activity (Flavell and Greenberg, 2008) . Among these IEG products, the activity-regulated cytoskeleton-associated protein Arc/Arg3.1 is particularly notable, since its mRNA is rapidly trafficked following neuronal stimulation, where it is locally translated (Lyford et al., 1995; Moga et al., 2004; Steward et al., 1998) . Arc regulates synaptic strength (Guzowski et al., 2000; Rial Verde et al., 2006; Shepherd et al., 2006; Waung et al., 2008) and promotes the endocytosis of AMPA receptors at glutamatergic synapses (Rial Verde et al., 2006; Shepherd et al., 2006; Waung et al., 2008) . Indeed, Arc directly binds dynamin-2 and endophilin-3, which are important components of the endocytic machinery . Recent findings have shown that Arc participates in multiple forms of synaptic plasticity, including homeostatic scaling (Gao et al., 2010; Korb et al., 2013; Shepherd et al., 2006) ; metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) (Jakkamsetti et al., 2013; Park et al., 2008; Waung et al., 2008) ; and inverse synaptic tagging, where it mediates endocytosis of AMPA receptors at inactive synapses that recently experienced strong stimulation (Okuno et al., 2012) . A large body of work has shown that activity-dependent endocytosis and AMPA receptor recycling mediate diverse forms of learning-related synaptic plasticity (Kessels and Malinow, 2009; Newpher and Ehlers, 2008) . Thus, the transient induction and tight regulation of Arc levels have been proposed to tune synaptic strength by adjusting postsynaptic trafficking of AMPA receptors. Notably, once induced, Arc undergoes rapid protein turnover (Rao et al., 2006) , ensuring a discrete temporal window for Arc-dependent plasticity.
Across phylogeny, protein degradation by the ubiquitin-proteasome system (UPS) regulates many aspects of synapse function (DiAntonio and Hicke, 2004; Mabb and Ehlers, 2010) . At mammalian hippocampal synapses, long-term alterations in synaptic activity cause global changes in the composition of postsynaptic proteins via the UPS (Ehlers, 2003) . Furthermore, long-term potentiation (LTP) at CA1 synapses in the hippocampus requires a balance between protein synthesis and proteasomal degradation (Fonseca et al., 2006) , suggesting that newly synthesized plasticity proteins are subject to ubiquitin-dependent turnover for reliable synapse function. Additionally, a variety of activity-induced proteins, including Arc, are degraded by the UPS (Greer et al., 2010; Rao et al., 2006) . However, the mechanisms by which Arc is targeted for UPS degradation and how Arc turnover is coupled to endocytic function remain poorly defined.
In the present study, we demonstrate that the RING domain E3 ubiquitin ligase Triad3A/RNF216 ubiquitinates Arc and promotes its proteasomal degradation. Using live-cell imaging and (A) Pulse-chase analysis of endogenous Arc. Cortical neurons at 14-18 days in vitro (DIV14-18) were treated with 40 mM 4AP and 50 mM Bic for 4 hr in the presence of 35 S-Cys/Met. Labeled neurons were chased with unlabeled amino acids for various times in the continued presence of 4AP/Bic. Cell lysates were immunoprecipitated with an anti-Arc antibody, resolved by SDS-PAGE, and visualized by autoradiography. The remaining labeled Arc was plotted over time.
Data indicate means ± SEM and half-life (t 1/2 ) is shown. n = 3. IB, immunoblot. (B) Endogenous Arc is upregulated and ubiquitinated upon 4AP/Bic treatment. DIV14 cortical neurons were incubated with 4AP/Bic for 1 and 4 hr. Endogenous Arc was immunoprecipitated (IP) under denaturing conditions, resolved by SDS-PAGE, and immunoblotted (IB) with an anti-ubiquitin (Ub) antibody. Brackets indicate polyubiquitinated Arc species. (C) Arc is ubiquitinated in vivo. Hippocampal extracts were isolated from mice following pilocarpine-induced seizures to elevate Arc levels. Endogenous ubiquitinated Arc was immunoprecipitated (IP) and detected as in (B) . 
RESULTS

Proteasomal Degradation Regulates Arc Turnover in Neurons
The translation of Arc mRNA is rapidly induced by synaptic activity in an N-methyl-D-aspartate receptor-dependent manner in vivo (Lyford et al., 1995; Steward and Worley, 2001) . We recapitulated this manipulation in vitro by treating cultured hippocampal neurons with 4-aminopyridine (4AP), a blocker of K v 1 family K + channels, together with the g-aminobutyric acid (GABA) receptor antagonist bicuculline (4AP/Bic), to enhance synaptic and network activity (Kawashima et al., 2009) . Using this protocol, Arc protein expression is robustly induced (Figure S1A available online) (Kawashima et al., 2009) . The 4AP/ Bic-induced increase in Arc protein was prevented by the Na + channel blocker tetrodotoxin (TTX; 2 mM) ( Figure S1A ). Following its induction by 4AP/Bic, Arc protein rapidly decays in the presence of protein synthesis inhibitors ( Figure S1A ), indicating the robust degradation of newly synthesized Arc. To measure the half-life of newly synthesized Arc following increased neuronal activity, we performed pulse-chase metabolic labeling experiments in cortical neurons. Newly synthesized Arc was radiolabeled with 35 S-cysteine/methionine ( 35 S-Cys/Met) under conditions of elevated activity (4AP/Bic). Neurons were then chased by incubation with unlabeled amino acids over time ( Figure 1A ). With elevated synaptic activity, we observed robust induction, followed by a rapid decay of labeled Arc protein. The half-life of newly synthesized Arc protein was 45 ± 10 min ( Figure 1A) , which is consistent with previous observations (Rao et al., 2006) .
To test whether the rapid degradation of Arc is mediated by the UPS, we incubated cortical neurons with the proteasome inhibitor MG132 (30 mM, 1 hr), following treatment with 4AP/ Bic. In addition to the induction of Arc protein by synaptic activity (3-fold induction compared to TTX, p < 0.05), Arc levels were further augmented upon treatment with MG132 (Figures S1B and S1C; 1.5-fold relative to 4AP/Bic alone, p < 0.05). We also observed increased Arc levels on MG132 treatment by immunocytochemical staining of hippocampal neurons (Figures S1D and S1E). Endogenous Arc protein was robustly induced and ubiquitinated in cortical neurons following treatment with 4AP/ Bic ( Figure 1B) . A similar increase in total and ubiquitinated Arc occurred in mouse hippocampus in vivo following seizure induction using pilocarpine ( Figure 1C) . Thus, upon increased activity, Arc protein is rapidly synthesized but then quickly degraded by the UPS both in vitro and in vivo.
Triad3A/RNF216 Interacts with Arc and Promotes Its Ubiquitination
To identify binding partners that regulate Arc degradation, we performed a yeast two-hybrid screen using full-length Arc as bait against a mouse brain complementary DNA (cDNA) library. We identified a strong interaction between Arc and the RING domain E3 ubiquitin ligase Triad3A/RNF216 ( Figure S1F ). Analysis of isolated clones mapped the interaction to the N-terminal domain of Triad3A upstream of the RING-IBR-RING domain (amino acids 201-470) and the C-terminal domain of Arc encompassing the spectrin-like homology repeats (amino acids 94-382) ( Figure 1D ). Triad3A was initially identified as a RING domain ubiquitin E3 ligase involved in the ubiquitination of toll-like receptors (Chuang and Ulevitch, 2004) . Triad3A is the major splice variant of Triad3, which encodes five splice variants, Triad3A-Triad3E (Chuang and Ulevitch, 2004) . Among these splice variants, Triad3A is most highly expressed in brain (Chuang and Ulevitch, 2004) , including hippocampus, neocortex, olfactory bulb, and cerebellum (Figures S1G and S1H). Biochemical fractionation indicated the presence of Triad3A protein in both presynaptic vesicle (S3) and postsynaptic density (PSD) fractions, although abundance in the PSD fraction was lower ( Figure 1E ). When coexpressed in HEK293T cells, myc-tagged Arc coimmunoprecipitated with Flag-tagged Triad3A and vice versa ( Figure 1F ). In addition, endogenous Arc protein coimmunoprecipitated with Triad3A from hippocampal extracts of mice on induction of Arc by pilocarpine-induced seizures ( Figure 1G ).
After transfecting human embryonic kidney 293 (HEK293) cells with Arc and increasing amounts of Triad3A cDNA, immunoblot analysis indicated a progressive loss of Arc protein with increased Triad3A (Figure 2A ). In addition, coexpression of myc-Arc with hemagglutinin (HA)-ubiquitin (HA-Ub) revealed robust Arc ubiquitination in the presence of Triad3A ( Figure 2B ). In contrast to wild-type Triad3A, expression of mutant Triad3A lacking the second RING domain (Triad3A-DR2) did not promote Arc ubiquitination ( Figure 2B ). The predominant Triad3 isoforms (E) Subcellular distribution of Triad3A in brain. Subcellular fractions from adult rat forebrain were immunoblotted for Triad3A, PSD-95, and synapsin I. For each lane, 25 mg of S1, P2, and P3 fractions, or 8 mg each of total synaptosomal plasma membrane (SPM) and S3 fractions, or 3 mg of PSD fractions (PSDI, PSDII, and PSDIII) were loaded for immunoblot analysis. Note that Triad3A is present in both S3 and PSDII fractions. WB, whole brain. 
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Triad3A Ubiquitinates Arc in the brain are Triad3A, -3D, and -3E (Chuang and Ulevitch, 2004) , splice variants that differ only in their N-terminal domains ( Figure S2A , top panel). Although variably spliced, Triad3C, Triad3D, and Triad3E encode for the same protein ( Figure S2A , top panel). Both Triad3A and Triad3B, but not Triad3C, promoted Arc ubiquitination ( Figure S2A ). Whereas Triad3A and Triad3B strongly induced Arc ubiquitination, the related RING-IBR-RING E3 ligase parkin did not ( Figure S2A ). Moreover, we did not detect ubiquitination of Arc upon coexpression with other known E3s that are expressed in the brain including Ube3a, Smurf1, Smurf2, and NEDD4-1 ( Figure 2C ). Previously, Ube3a was identified as a ubiquitin E3 ligase for Arc (Greer et al., 2010) . In contrast to Triad3A, we were unable to detect Ube3a-dependent Arc ubiquitination ( Figure 2C ), similar to recent findings (Kü hnle et al., 2013) . However, expression of wild-type Ube3a, but not the catalytically inactive mutant Ube3a (C883A), reduced Arc protein levels ( Figure S2B ), as previously reported (Greer et al., 2010) . Compared to Triad3A, which efficiently coimmunoprecipitated with Arc, we were unable to detect an interaction between Ube3a and Arc in HEK293 cells ( Figure 2D ). However, we did observe a weak interaction between endogenous Ube3a and Arc in hippocampal neurons ( Figure S2C ). Knockdown of Triad3A in hippocampal neurons did not increase the interaction between Arc and Ube3a, suggesting that Triad3A does not compete with Ube3a for Arc binding ( Figure S2C ). Using in vitro ubiquitination assays, we found that Triad3A efficiently ubiquitinated fulllength recombinant Arc, whereas Ube3a did not ( Figure 2E ; compare lanes 4 and 8). We then purified a fragment of Arc (amino acids 132-396) that lacks the N-terminal coiled coil and endophilin-3 binding domains and was previously demonstrated to be a Ube3a substrate in vitro (Greer et al., 2010) . Both Triad3A and Ube3a could ubiquitinate this Arc fragment ( Figure 2F ). However, unlike the high-molecular-mass polyubiquitinated smear observed with full-length Arc ( Figure 2E ), we observed a small $7 kDa shift in molecular weight to an apparent single species ( Figure 2F ). Finally, cortical neurons from Ube3a mÀ/p+ mice were examined for Arc K48-linked polyubiquitination using a K48 linkage-specific antibody that recognizes the predominant ubiquitin chain associated with proteasome-dependent degradation (Newton et al., 2008) . Immunoprecipitation and immunoblot analysis revealed an increase in Arc protein levels in Ube3a mÀ/p+ cortical neurons compared to wild-type neurons as previously described (Greer et al., 2010 ) ( Figure 2G ). However, we also detected an increase in K48-linked Arc ubiquitin conjugates, indicating that Arc is still capable of being ubiquitinated in the absence of Ube3a ( Figure 2G ).
Triad3A Ubiquitinates Arc at Lysines 268 and 269
To determine which region of Arc serves as the target for Triad3A-dependent ubiquitination, we coexpressed FlagTriad3A and HA-Ub with various Arc deletion mutants lacking the coiled-coil domain (DCC), endophilin-3 binding domain (DEB), and spectrin-repeat homology domains (DSRH) (Figure 3A) . Deletion of the SRH domain of Arc abolished ubiquitination by Triad3A ( Figure 3A ). To identify the lysine residue(s) of Arc that is (or are) ubiquitinated by Triad3A, we performed mass spectrometry on purified Arc following in vitro ubiquitination with Triad3A. His-tagged Arc was purified from insect cells, and Flag-tagged Triad3A was isolated from HEK293 cells (Figure S3A) . When screening various E2 proteins, we found that both UbcH5 and UbcH7 efficiently supported Triad3A-dependent ubiquitination of Arc in vitro ( Figure S3B ). We then performed in vitro Arc ubiquitination assays in the presence of E1, E2 (UbcH7), recombinant His-Arc, Flag-Triad3A, and purified ubiquitin lacking internal lysines ( Figure S3C ). Arc was purified under denaturing conditions, resolved by SDS-PAGE, stained with Coomassie blue ( Figure S3C ), band isolated, and subjected to in-gel trypsin digestion for liquid chromatography and tandem mass spectrometry analysis. Our analysis identified four lysines (K55, K136, K268, and K293) as sites of ubiquitination (Figure 3B) . Of these sites, lysines 55 and 268 were ubiquitinated by Triad3A in more than one experiment ( Figure 3B ). We next mutated candidate lysine residues and coexpressed Arc mutants with Triad3A in HEK293 cells. Single-site mutation of each of the four lysines (K55A, K136A, K268A, and K293A) had no effect on Triad3A-induced ubiquitination ( Figure 3C ). However, we noted the presence of a conserved lysine residue adjacent to K268 that was not identified in the mass spectrometric analysis. Indeed, whereas Arc-K268A and Arc-K269A were each robustly ubiquitinated by Triad3A, mutation of both residues to alanine almost completely abolished Triad3A-induced ubiquitination ( Figure 3C ). Similar results were obtained with a lysine-to-arginine double mutant Arc-K268R/K269R (data not shown). We then coexpressed wild-type Arc (Arc-WT) or Arc-K268R/K269R (hereinafter referred to as Arc-KR) in HEK293 cells and performed 35 S-Cys/Met metabolic labeling and pulse-chase analysis. Introduction of K268R and K269R mutations significantly slowed Arc degradation ( Figures 3D and 3E ). Since Arc decay was still observed in the Arc-KR mutant, we mutated all lysines of Arc (K55R/K136R/K268R/K269R/K293R) that were identified as being ubiquitinated (referred to as Arc-ALL) and monitored decay of protein levels following cyclohexamide treatment ( Figure S3D ). As expected, Arc-KR levels decayed slower than Arc-WT ( Figure S3D ). However, we did not observe a difference in decay between Arc-KR and Arc-ALL, suggesting that UbcH7, and 10 mg of recombinant ubiquitin. Samples were incubated for 2 hr at 30 C, resolved by SDS-PAGE, and subjected to immunoblot (IB) analysis with anti-Arc antibody to detect ubiquitin conjugates or anti-HA and anti-Flag antibodies to detect immunopurified E3s. Immunopurified HA-Ube3a and FLAG-Triad3A are both active as they are capable of self-ubiquitination. Whereas high molecular mass ubiquitin conjugates of Arc (1-396) were observed with Triad3A in (E), a single apparent monoubiquitinated species of Arc (132-396) was observed with both Triad3A and Ube3a in (F) (mono-Ub). Molecular mass markers in kilodaltons are shown on the left. (G) Arc levels are increased and Arc ubiquitin conjugates are present in neurons lacking Ube3a. Cortical neurons DIV14 from Ube3a mÀ/p+ mice were treated with K268 and K269 are the primary sites of Arc ubiquitination ( Figures  S3D and S3E ). The continued degradation of Arc-KR and Arc-ALL could be due to the presence of a strong predicted PEST motif that is located at the C terminus of Arc (Rao et al., 2006) .
Triad3A Regulates Arc Turnover in Neurons
To examine the role of endogenous Triad3A in regulating Arc stability, we utilized RNA interference (RNAi) for loss-of-function analysis. We identified two short hairpin RNA (shRNA) sequences 
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Triad3A Ubiquitinates Arc that efficiently reduced Triad3A protein levels ( Figure S4 ). Expression of these shRNAs in hippocampal neurons decreased Triad3A immunostaining by approximately 75% (Figures S4C  and S4D ). Lentiviral transduction of Triad3 shRNA resulted in a significant reduction of endogenous Triad3A relative to a scrambled shRNA control ( Figure S4E ). We next examined Arc expression elicited by 4AP/Bic in hippocampal neurons transduced with Triad3 shRNA ( Figure 4A ) and observed an increase in Arc accumulation compared to scrambled control (2.6 ± 0.4 fold increase, p < 0. 4D ). Immunoblot analysis of total Arc from radiolabeled lysates confirmed the persistence of Arc following 4AP/Bic in neurons lacking Triad3A ( Figure 4C) .
In further experiments, we monitored endogenous Arc in hippocampal neurons upon Triad3A overexpression or knockdown in the presence or absence of elevated synaptic activity (Figure 4E ). As expected, 4AP/Bic treatment increased Arc levels within 4 hr ( Figures 4E and 4F ). In neurons with reduced levels of Triad3A, activity-induced Arc levels were increased by 2-fold ( Figures 4E and 4F) . Coexpression of RNAi-resistant Triad3A reversed the increase in Arc ( Figure 4F ). In addition, overexpression of Triad3A blocked the activity-induced increase in Arc, resulting in Arc levels that were similar to those observed without activity ( Figures 4E and 4F) . Furthermore, knockdown of Triad3A abolished 4AP/Bic-induced Arc ubiquitination in cortical neurons ( Figure 4G ).
Triad3A Associates with Arc at Sites of Endocytosis
Recent studies have found that Arc facilitates the endocytosis of AMPA receptors through interactions with dynamin-2 and endophilin-3 Rial Verde et al., 2006; Shepherd et al., 2006) . We investigated whether Triad3A-mediated Arc ubiquitination affects the kinetics and localization of Arc within the endocytic pathway. In COS7 cells, green fluorescent protein (GFP)-tagged Triad3A puncta colocalized with clathrinDsRed, which marks sites of endocytosis ( Figures 5A and 5B) . Furthermore, mCherry-Triad3A puncta colocalized with the clathrin endocytic adaptor, GFP-Eps15 ( Figure 5A , bottom panel), and GFP-dynamin 2 (data not shown). We next coexpressed GFP-Triad3A with DsRed-tagged clathrin light chain in COS7 cells and examined surface colocalization using total internal reflection fluorescence microscopy (TIRFM) . TIRFM revealed punctate spots of GFP-Triad3A that colocalized with clathrin ( Figure 5C ; Figures S5A and S5B) . We also observed colocalization of Arc and Triad3A in COS7 cells, albeit to a lesser degree ( Figures 5B and S5C) .
Using live-cell TIRFM imaging, compared to Arc, Triad3A persisted for longer periods at membrane puncta (Triad3A, 27.1 ± 2.3 s; Arc-WT, 10.2 ± 1.0 s; Figures 5C-5F , 5H, and S5D; Movies S1 and S2). The transient association of Arc with clathrin-coated pits (CCPs) is similar to the reported dynamics of its interacting partners, endophilin-3 and dynamin-2 . Mutations of the K268 and K269 ubiquitination sites of Arc (Arc-KR) resulted in a more stable association at the membrane (17.3 ± 1.6 s) (Figures 5E, 5G, 5H and S5E; Movie S3). It is intriguing that Arc-KR puncta were near but seldom directly overlapped with CCPs, suggesting that Triad3A-dependent ubiquitination might couple Arc to sites of endocytosis or prevent persistent association of Arc with endocytic intermediates following clathrin uncoating Wu et al., 2011) . In neurons, GFP-Triad3A colocalized with clathrin-DsRed in dendritic shafts and spines of hippocampal neurons ( Figure 6A) but not with the postsynaptic density marker Homer-DsRed ( Figure 6B ). To test whether Triad3A localizes to the endocytic zone (EZ) within spines, we coexpressed GFP and clathrin-DsRed in hippocampal neurons and immunostained for endogenous Triad3A ( Figure 6C ). Endogenous Triad3A in dendritic spines tightly overlapped with clathrinDsRed within a subdomain of the spine ( Figure 6C ). Consistent with the lateral localization of the EZ, Triad3A staining was localized adjacent to the PSD ( Figure 6D ). The percentage of PSDs containing adjacent Triad3A puncta was 55% ± 5%, which is slightly lower than previous findings for EZ-positive spines (Blanpied et al., 2002; Lu et al., 2007) . Furthermore, Triad3A did not tightly overlap with syntaxin-4, a marker of exocytic domains within dendritic spines ( Figure S5F ) (Kennedy et al., 2010) . To examine the synaptic distribution of Triad3A in vivo, we performed immunogold electron microscopy (EM) of rat CA1 hippocampus. Triad3A immunogold labeling was present near the membrane and on vesicle-like structures in both presynaptic terminals and postsynaptic spines ( Figure 6E ), similar to our biochemical observations ( Figure 1E ). Quantitative analysis indicated that a significant fraction (>30%) of gold particles were positioned along the plasma membrane near the PSD ( Figure 6E , black arrows), with a 2-fold decrease in Triad3A labeling at spine membrane locations further away from the PSD ( Figure 6F ).
Triad3A Is Required for Arc-Dependent Synaptic Plasticity Postsynaptic endocytosis regulates synaptic AMPA receptor levels (Lü scher et al., 1999; Newpher and Ehlers, 2008) , and Arc is known to facilitate AMPA receptor endocytosis Rial Verde et al., 2006; Waung et al., 2008) . Regulation of Arc levels results in reciprocal changes in the expression of surface AMPA receptors that can occur under baseline conditions and is most robust on chronic changes in synaptic activity (Bé ïque et al., 2011; Craig et al., 2012; Gao et al., 2010; Shepherd et al., 2006; Waung et al., 2008) . We reasoned that a reduction of Triad3A should phenocopy Arc overexpression, whereas overexpression of Triad3A should mimic effects of Arc knockdown or knockout (KO). Consistent with this notion, shRNA knockdown of Triad3A led to increased endocytosis of the AMPA receptor subunit, GluA1 ( Figures 6G  and 6I ). Conversely, overexpression of Triad3A decreased endocytosis of GluA1 AMPA receptors ( Figures 6G and 6I ), similar to that observed in Arc KO neurons . Notably, shRNA knockdown of Triad3A decreased GluA1 receptor levels at the cell surface ( Figures S6A and S6B) , and this effect could be rescued by coexpressing an RNAi-resistant form of Triad3A ( Figure S6B ). Conversely, overexpression of Triad3A produced an increase in surface AMPA receptors ( Figures S6A and S6B ), similar to that observed in Arc KO neurons. Thus, Triad3A and Arc exert reciprocal effects on AMPA receptor surface trafficking. To determine if Triad3A functions in the same endocytic pathway as Arc to mediate GluA1 endocytosis, we coexpressed Endophilin 3 (Endo3-WT) and a dominant negative version of Endophilin 3 (172-347) (Endo3-CT) that interacts with Arc and interferes with Arc-induced AMPAR endocytosis . As described earlier ( Figures  6G and 6I) , expression of Triad3 shRNA increased GluA1 endocytosis compared to scrambled shRNA control (Scr) ( Figures  S6C and S6D) . However, coexpression of Triad3-shRNA with Endo3-CT prevented this increase in GluA1 endocytosis mediated by Triad3-shRNA ( Figures S6C and S6D ). Triad3A-dependent Arc ubiquitination occurs on K268 and K269. To examine if ubiquitination of Arc by Triad3A mediates GluA1 endocytosis, we coexpressed Arc-WT or Arc-KR with Triad3A. Overexpression of Triad3A reduced GluA1 endocytosis, and this was not affected by coexpression of Arc-WT ( Figures 6H and 6J ). However, expression of Arc-KR stimulated GluA1 endocytosis, despite coexpression of Triad3A ( Figures 6H and 6J ), indicating that Triad3A negatively regulates GluA1 endocytosis by ubiquitination of Arc at K268/269. Arc is required for multiple forms of activity-dependent synaptic plasticity, including homeostatic scaling, hippocampal LTP, and protein synthesis-dependent LTD (Gao et al., 2010; Guzowski et al., 2000; Jakkamsetti et al., 2013; Rial Verde et al., 2006; Shepherd and Bear, 2011; Shepherd et al., 2006; Waung et al., 2008) . In hippocampal neurons, overexpression of Triad3A mimicked and occluded TTX-induced upregulation as measured by surface expression of synaptic GluA1 (Figures 7A and 7B ). In contrast, Triad3A knockdown blocked the scaling effects of TTX ( Figures 7A and 7C ). To confirm our findings, we tested the effect of Triad3A on miniature excitatory postsynaptic currents (mEPSCs) following chronic activity manipulations. Whereas Triad3A overexpression mimicked and occluded the increase of mEPSC amplitudes normally induced by TTX treatment (48 hr, 1 mM), Triad3A knockdown prevented any TTX-induced increase in mEPSC amplitudes ( Figures 7D-7H ). Given the inverse relationship between Arc levels and its ubiquitinating enzyme Triad3A, these data support a model whereby negative regulation of Arc by Triad3A mediates TTX-induced upscaling .
Arc synthesis is required for LTD elicited by the mGluR1/5 agonist 3,5-dihydroxyphenylglycine (DHPG) in CA1 hippocampus, a form of synaptic plasticity termed mGluR-LTD (Waung et al., 2008) . We reasoned that, by targeting Arc for degradation, Triad3A might act to dampen or limit mGluR-LTD. In control neurons expressing GFP, bath application of DHPG (100 mM, 10 min) led to a robust depression of mEPSC amplitudes and frequency ( Figures 8A and 8E) . Overexpression of GFP-Triad3A prevented this mGluR-induced synaptic depression (Figures 8B and 8E; percent reduction: GFP, 22% ± 1%; GFP-Triad3A, À2% ± 3%), consistent with a reduction in activity-induced Arc ( Figures 4E and 4F) . We then knocked down Triad3A by expressing Triad3-shRNA in hippocampal neurons ( Figure 8D ). In control neurons expressing a scrambled shRNA, DHPG application produced a significant depression of mEPSC amplitude and frequency ( Figures 8C and 8F) . Notably, in neurons expressing Triad3-shRNA, we observed a larger decrease in mGluR-dependent mEPSC amplitude, with a nearly 2-fold greater reduction in mEPSC amplitudes relative to Scr control ( Figures 8C, 8D , and 8F; percent reduction: Scr, 12% ± 3%; Triad3-shRNA, 21% ± 2%), supporting the hypothesis that control of Arc levels by Triad3A determines the degree or extent of synaptic depression induced by mGluR activation.
DISCUSSION
In the present study, we have identified Triad3A/RNF216 as an E3 ubiquitin ligase targeting Arc-an activity-regulated gene product that regulates AMPA receptor endocytosis and synaptic plasticity. We have demonstrated that Triad3A is present at CCPs, including endocytic zones of dendritic spines. By limiting Arc protein levels induced by synaptic activity, Triad3A regulates Arc-dependent forms of synaptic plasticity. Our findings support a model, in which the upregulation and recruitment of Arc to the endocytic machinery is coupled to its ubiquitination and degradation by Triad3A.
An Ubiquitin-Dependent Brake on Arc-Induced Plasticity Many forms of synaptic plasticity are expressed by the insertion or removal of AMPA receptors from the postsynaptic membrane (Kessels and Malinow, 2009; Malenka and Bear, 2004; Newpher and Ehlers, 2008) . In response to learning-related synaptic activity and protein-synthesis-dependent LTD, Arc is rapidly induced (Guzowski et al., 1999; Lü scher and Huber, 2010; Lyford et al., 1995; Steward et al., 1998) and facilitates endocytosis of synaptic AMPA receptors (Waung et al., 2008) . Arc-mediated endocytosis of AMPA receptors dampens excitatory synaptic transmission, and this compensatory decrease in synaptic strength mediates homeostatic plasticity Rial Verde et al., 2006; Shepherd et al., 2006) . Here, we have shown that Arc half-life and, hence, Arc levels are determined by ubiquitin-dependent degradation mediated by Triad3A. Triad3A binds to Arc and ubiquitinates Arc at lysines 268 and 269. Furthermore, Triad3A is required for homeostatic synaptic upscaling and mGluR-induced synaptic depression. Although Triad3A is required for TTX-induced upscaling of synaptic strength, manipulations of Triad3A did not significantly influence downscaling of AMPA receptors following Bic treatment (data not shown). These findings are consistent with those of Shepherd et al., who found a larger effect of Arc on TTX-induced upscaling, whereas Arc KO neurons were still capable of synaptic depression induced by Bic . Thus, Triad3A and Arc share similar properties for synaptic scaling. In addition, we have shown that Triad3A exerts tonic negative regulation of mGluR-induced synaptic depression, consistent with previous work demonstrating that Arc synthesis is required for mGluR-LTD (Waung et al., 2008) and further supporting Triad3A's role in mediating Arc. By controlling Arc levels via ubiquitination and UPS-dependent degradation, Triad3A limits AMPA receptor endocytosis and associated synaptic depression.
In addition to regulating rapid forms of synaptic plasticity, loss of Arc or deletion of the endophilin binding domain of Arc both prevent forms of homeostatic synaptic plasticity (Bé ï-que et al., 2011; Gao et al., 2010; Shepherd et al., 2006) that globally scale AMPA receptor-dependent synaptic currents (Turrigiano, 2008) . Such slow forms of homeostatic plasticity are known to require ubiquitin-dependent degradation and remodeling of the PSD. The translation of Arc mRNA is rapidly induced by activation of group I mGluRs, and this synthesis of Arc is coupled to depression of synaptic strength in a manner regulated by the fragile X mental retardation protein (FMRP) (Niere et al., 2012; Park et al., 2008; Waung et al., 2008) . We found that disruption of the dynamic cycle of Arc induction and subsequent degradation by knockdown of Triad3A prevents mGluR-dependent synaptic depression. Given the role of Arc in executing both rapid and more chronic forms of synaptic plasticity, an attractive model is that Arc protein levels are under continuous online regulation via regulated synthesis and degradation, the latter of which is controlled by Triad3A. These findings are supported by recent work, which demonstrates that Arc levels dictate the ability of a cell to elicit mGluR-LTD (Jakkamsetti et al., 2013) . One prediction of this model is that alteration of Triad3A can trigger both immediate and longer term effects on synaptic strength that depend on ongoing synaptic activity, patterns of receptor activation, and homeostatic compensation. Our findings strongly suggest that Triad3A couples protein synthesis to protein turnover by targeting Arc for ubiquitin-dependent degradation at excitatory synapses.
Triad3A as a Ubiquitin Ligase in the Endocytic Pathway
Arc interacts with dynamin-2 and endophilin-3, and this interaction is necessary for Arc-mediated endocytosis of AMPA receptors (Bramham et al., 2008; Chowdhury et al., 2006) . When Arc is expressed in HeLa cells, it localizes to both the cytoplasm and nucleus with partial enrichment at the plasma membrane . This localization pattern is altered upon coexpression with endophilin and dynamin, which results in a redistribution of Arc to endosomal structures . Using TIRFM, we found that a pool of Arc localizes to CCPs in COS7 cells. This finding, along with an increased surface lifetime of Arc-KR, suggests that, following activityinduced synthesis, Arc is recruited to the cell surface by molecular interactions with endophilin-3 and dynamin-2, where it encounters Triad3A residing at CCPs for subsequent ubiquitination and UPS-mediated degradation. Although our findings support a temporal relationship between Arc synthesis, coated pit association, and Triad3A-mediated ubiquitination, it will be important for future studies to elucidate the precise timing and kinetics of Triad3A-mediated Arc ubiquitination before, during, and after a period of facilitated endocytosis.
Similar to other UPS targets, the addition and removal of ubiquitin chains on Arc likely reflect the competing activity of other ubiquitin ligases and deubiquitinating enzymes, as well as other ubiquitin-like modifications such as SUMOylation (Craig et al., 2012) . Moreover, ubiquitination of Arc by Triad3A at CCPs could facilitate interactions with other endocytic proteins such as Eps15, Eps15R, and epsin that normally localize to CCPs and contain ubiquitin-binding motifs (Di Fiore et al., 2003) . We observed a large fraction of Arc events at the cell surface that did not colocalize with CCPs but did colocalize with Triad3A, suggesting that Arc may also function in dynamin-dependent but clathrin-independent pathways to regulate endocytosis (Hansen and Nichols, 2009) . Overall, the Triad3A-Arc pathway defined here reveals a mechanistic link between the UPS, AMPA receptor endocytosis, and activity-dependent plasticity. Beyond the nervous system, such a mechanism may provide a general paradigm for the transient modification of endocytosis in diverse tissues.
Regulating the Stability of Arc
In a recent study, the HECT domain E3 ligase Ube3a, whose maternal copy loss causes Angelman syndrome (Kishino et al., 1997) , was found to be a direct modulator of Arc (Greer et al., 2010) . We were unable to detect Arc ubiquitination by Ube3a in HEK293 cells, even though we found that Ube3a overexpression reduced Arc protein levels in the same system as reported (Greer et al., 2010) . Furthermore, we failed to detect Ube3a-dependent polyubiquitination of full-length Arc but could detect Ube3a-dependent monoubiquitination on a recombinant C-terminal Arc fragment (132-396) as reported (Greer et al., 2010) . Finally, although we could detect a weak interaction between Arc and Ube3a in neurons, we were unable to detect a loss of Arc ubiquitination in Ube3a null neurons. Our findings are consistent with a recent study showing that Ube3a does not promote ubiquitination of Arc (Kü hnle et al., 2013) . It is intriguing that we found that the same two lysine residues on Arc (K268 and K269) reported to be ubiquitinated by Ube3a (Greer et al., 2010) are direct acceptor sites for ubiquitination by Triad3A. Ube3a may regulate Arc degradation following prolonged changes in synaptic activity, whereas Triad3A may be involved in the steady-state turnover of Arc under basal synaptic transmission and on more immediate increases or decreases in synaptic drive. The exact molecular interplay between Arc, Triad3A, and Ube3a remains to be elucidated. 
Neuron
Triad3A Ubiquitinates Arc
It is interesting that, as with Ube3a, there may be a link between Triad3A and neurodevelopmental disorders. A recent report described an autistic patient carrying a t(7;16)(22.1; p11.2) reciprocal translocation that results in a highly selective 30-fold increase in the expression of the human Triad3 ortholog RNF216 (also called Q6NUR6, U7I1, UBCE7IP1, and MMD2) at chromosome 7p22.1 (Bayou et al., 2010) . The RNF216 gene is one of the genes deleted in a patient with severe colorectal cancer who also exhibits intellectual impairment, but lacks a brain tumor . Moreover, mutations and disruptions in the Triad3/RNF216 gene have recently been described in patients with Gordon Holmes syndrome characterized by ataxia, dementia, and hypogonadotropism accompanied by neuronal loss and intranuclear inclusions in the cerebellum and hippocampus (Margolin et al., 2013) . These findings suggest that increasing or decreasing levels of Triad3A could contribute to human intellectual disorders, potentially via modulation of Arc. More broadly, local regulation of Arc by Triad3A may provide a general paradigm for tuning the timing and duration of activitydependent plasticity in diverse neural circuits. 
In Vitro Ubiquitin Assays
In vitro ubiquitination of Arc was performed using 0.1 mg of recombinant ubiquitin E1 (Boston Biochem), 0.5 mg recombinant ubiquitin E2 (UbcH7; Boston Biochem), 10 mg of recombinant ubiquitin (Boston Biochem), and 0.1 mg immunopurified Flag-Triad3A added to 0.25 mg of His-tagged Arc (or 0.15 mg of glutathione S-transferase [GST]-Arc full-length or GST-Arc 132-396) in the presence of an ATP regenerating system (10 mM creatine phosphate, 10 U creatine kinase, 1 U inorganic pyrophosphatase, and 2 mM ATP) in 50 mM Tris (pH 7.6) and 5 mM MgCl 2 in a 120 ml reaction with 1 mg/ml aprotinin and 1 mM phenylmethylsulfonyl fluoride (PMSF). GST-Arc was purchased from BD Pharmingen. GST-Arc (132-396) was expressed and purified as described elsewhere Greer et al., 2010) . The reaction was incubated at 30 C for 120 min. Reactions were terminated by boiling samples in SDS-PAGE loading buffer, polypeptides were resolved by SDS-PAGE gel, and immunoblot analysis was performed with an anti-His antibody to detect ubiquitinated bands or with anti-Flag antibody to detect immunopurified Flag-Triad3A. For additional assay information, see Supplemental Experimental Procedures.
Electrophysiology
Homeostatic Scaling and Baseline mEPSC Recordings
Neurons were held at À65 mV using a MultiClamp 700B amplifier (Molecular Devices) controlled with a computer running MultiClamp Commander and pClamp (Molecular Devices), filtered at 2 kHz, and digitized at 40 kHz (Digidata 1440A, Molecular Devices). Only cells with stable series resistance <30 MU were included for analysis. Data were analyzed offline using ClampFit (Molecular Devices) or MiniAnalysis software (Synaptosoft). Detection criteria for mEPSCs included amplitude greater than 8 pA and rise times from the onset to the peak of less than 5 ms. Only recordings maintained more than 10 min were analyzed. For details, see the Supplemental Experimental Procedures.
DHPG-Induced Synaptic Depression
Recordings of mEPSCs were performed in hippocampal neurons obtained at a holding potential of À75 mV using an Axon Multiclamp 700B amplifier (Molecular Devices), filtered at 3 kHz, and digitized at 20 kHz (Digidata 1440A, Molecular Devices). Data acquisition was performed using pClamp 10 (Molecular Devices). Analysis of mEPSCs was performed using MiniAnalysis software (SynaptoSoft). Events were manually analyzed and were accepted if they had an amplitude >6 pA (events below this amplitude were difficult to distinguish from baseline noise) and a faster rise than decay. Cumulative probability 
